Bank of America Corporation »

Avalo Therapeutics Ord shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2024-06-30 $70k 5.6k 12.47

More positions owned by Bank of America Corporation

Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Grw Etf (IWF)
JPMorgan Chase & Co. (JPM)

View all positions for Bank of America Corporation

Top funds holding Avalo Therapeutics Ord

Logos Global Management
Sio Capital Management
Ikarian Capital
Affinity Asset Advisors
Commodore Capital
Vanguard Group
Bank of America Corporation
Royal Bank of Canada
Banque Cantonale Vaudoise
BlackRock
Morgan Stanley
Efficient Wealth Management
Bnp Paribas Arbitrage, Snc
Group One Trading
Jpmorgan Chase & Co

View all funds holding Avalo Therapeutics Ord